Advanced search
Start date
Betweenand
(Reference retrieved automatically from SciELO through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Increased modifiable cardiovascular risk factors in patients with Takayasu arteritis: a multicenter cross-sectional study

Full text
Author(s):
Alexandre Moura dos Santos ; Rafael Giovani Misse ; Isabela Bruna Pires Borges ; Bruno Gualano ; Alexandre Wagner Silva de Souza ; Liliam Takayama ; Rosa Maria R. Pereira ; Samuel Katsuyuki Shinjo
Total Authors: 8
Document type: Journal article
Source: ADVANCES IN RHEUMATOLOGY; v. 61, p. -, 2021.
Abstract

Abstract Background: Modifiable cardiovascular risk factors (MCRFs), such as those related to aerobic capacity, muscle strength, physical activity, and body composition, have been poorly studied in Takayasu arteritis (TAK). Therefore, the aim of the study was to investigate MCRFs and their relationships with disease status and comorbidities among patients with TAK. Methods: A multicenter cross-sectional study was conducted between 2019 and 2020, in which 20 adult women with TAK were compared with 16 healthy controls matched by gender, age, and body mass index. The following parameters were analyzed: aerobic capacity by cardiopulmonary test; muscle function by timed-stands test, timed up-and-go test, and handgrip test; muscle strength by one-repetition maximum test and handgrip test; body composition by densitometry; physical activity and metabolic equivalent by IPAQ, quality of life by HAQ and SF-36; disease activity by ITAS2010 and NIH score; and presence of comorbidities. Results: Patients with TAK had a mean age of 41.5 (38.0-46.3) years, disease duration of 16.0 (9.5-20.0) years, and a mean BMI of 27.7±4.5 kg/m2. Three out of the 20 patients with TAK had active disease. Regarding comorbidities, 16 patients had systemic arterial hypertension, 11 had dyslipidemia, and two had type 2 diabetes mellitus, while the control group had no comorbidities. TAK had a significant reduction in aerobic capacity (absolute and relative VO2 peak), muscle strength in the lower limbs, increased visceral adipose tissue, waist-to-hip ratio, reduced walking capacity, decreased weekly metabolic equivalent, and quality of life (P< 0.05) as compared to controls. However, there were no correlations between these MCRFs parameters and disease activity. Conclusions: TAK show impairment in MCRFs; therefore, strategies able to improve MCRF should be considered in this disease. (AU)

FAPESP's process: 19/11367-9 - Molecular and metabolic analysis of Atorvastatin in the muscle tissues of patients with Systemic Autoimmune Myopathies
Grantee:Isabela Bruna Pires Borges
Support type: Scholarships in Brazil - Doctorate
FAPESP's process: 19/12155-5 - Relevance and safety of non-invasive cerebral neuromodulation in patients with systemic autoimmune myopathies: double-blind, randomized, sham-controlled study
Grantee:Rafael Giovani Misse
Support type: Scholarships in Brazil - Doctorate
FAPESP's process: 18/08735-3 - Aerobic capacity and strength exercise in Takayasu's arteritis: relationships and impacts on clinical, laboratory and vascular end points
Grantee:Alexandre Moura dos Santos
Support type: Scholarships in Brazil - Master